Skin cancer Board decisions

The Board remands the matter for a VA examination and medical opinion regarding the Veteran's metastatic malignant melanoma to determine if it is related to service, including exposure to herbicide agents.

The Board granted service connection for bilateral macular hemorrhage, resolving all doubt in the Veteran's favor. The claims for other disabilities were remanded for further development.

The appeal for service connection for skin cancer was dismissed due to untimeliness, while the claim for squamous cell carcinoma was granted.

The appeal was dismissed due to the Veteran's death during the pendency of the claims.

The Board remands the claim for a compensable initial disability rating for scar tissue due to skin cancer because the evidence is unclear regarding the extent and nature of the scar tissue.

The Board granted service connection for skin cancer as secondary to the Veteran's service-connected liver disability, based on a positive nexus opinion from his treating physician and supporting medical evidence.

The Board granted service connection for melanoma of the right ear, finding that the evidence is in approximate balance and supports a nexus to Agent Orange exposure during service.

Service connection for prostate cancer on an accrued basis was granted based on the benefit-of-the-doubt doctrine, finding competent and credible evidence at least approximately balanced between service-connected prostatitis and prostate cancer. Service connection was denied for stomach cancer, colon cancer, skin cancer, the Veteran's cause of death, and dependency indemnity compensation benefits.

The Board remands the appeal to the AOJ for correction of an error on the part of the AOJ and to obtain additional evidence.

The Board remands the claims for service connection for melanoma of the skin and basal cell carcinoma due to a need for a VA examination and medical opinion.

The Board denied service connection for skin cancer, including as due to participation in toxic exposure risk activity (TERA), finding no evidence of the disease during service or within a year after separation and noting that the earliest diagnosis was nearly 25 years post-service.

The Board remands the issue of entitlement to service connection for skin cancer, including basal cell carcinoma and melanoma, due to an inadequate VA medical opinion.

The Board remands the claims for service connection for migraine headaches and skin cancer as additional development is necessary to correct pre-decisional duty to assist errors.

The Board granted an effective date of March 8, 2024 for the grant of service connection for type 2 diabetes mellitus but denied earlier effective dates for atrial fibrillation and congestive heart failure. The other claims were remanded.

The Board denied service connection for colon cancer, skin cancer, and prostate cancer. The Veteran was granted a 20% rating for right knee osteoarthritis status post meniscectomy with instability or subluxation and a 10% rating for a right knee scar.

The Board denied service connection for Barrett's esophagus, skin cancer, and ocular migraines as the evidence did not support a finding that these conditions were related to the Veteran's active military service.

The Board remands the claim for an initial compensable evaluation of skin cancer to ensure a VA examination is conducted to determine the severity of the disability.

The Board granted service connection for basal cell carcinoma, melanoma, and obstructive sleep apnea based on toxic exposure risk activity (TERA) during the Veteran's service.

The Board granted the restoration of a 100 percent evaluation for malignant melanoma of the skin, effective from May 15, 2025.

The Board granted service connection for an acquired psychiatric disability and skin cancer, but denied service connection for hemochromatosis.